Skip to main content
. 2015 Apr 10;172(12):3141–3150. doi: 10.1111/bph.13116

Figure 4.

Figure 4

Characterization of the effect of VEGF165b on NFAT-luciferase repsonses. (A) A comparison of VEGF165a and VEGF165b concentration–response curves. (B) Inhibition of VEGF165b-stimulated NFAT-luciferase responses by cediranib. In (B), the concentration of VEGF165b was 3 nM. Data are mean ± SEM of five separate experiments. Four replicates were made for each condition in each individual experiment.